Sonic Healthcare Limited Stock Fundamentals

SKHCF Stock  USD 17.95  0.71  4.12%   
Sonic Healthcare Limited fundamentals help investors to digest information that contributes to Sonic Healthcare's financial success or failures. It also enables traders to predict the movement of Sonic Pink Sheet. The fundamental analysis module provides a way to measure Sonic Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sonic Healthcare pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sonic Healthcare Limited Company Return On Equity Analysis

Sonic Healthcare's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Sonic Healthcare Return On Equity

    
  0.22  
Most of Sonic Healthcare's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sonic Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Sonic Healthcare Limited has a Return On Equity of 0.2175. This is 100.91% lower than that of the Healthcare sector and 103.26% lower than that of the Diagnostics & Research industry. The return on equity for all United States stocks is 170.16% lower than that of the firm.

Sonic Healthcare Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sonic Healthcare's current stock value. Our valuation model uses many indicators to compare Sonic Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sonic Healthcare competition to find correlations between indicators driving Sonic Healthcare's intrinsic value. More Info.
Sonic Healthcare Limited is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.51  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sonic Healthcare Limited is roughly  1.96 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sonic Healthcare's earnings, one of the primary drivers of an investment's value.

Sonic Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sonic Healthcare's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sonic Healthcare could also be used in its relative valuation, which is a method of valuing Sonic Healthcare by comparing valuation metrics of similar companies.
Sonic Healthcare is currently under evaluation in return on equity category among its peers.

Sonic Fundamentals

About Sonic Healthcare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sonic Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sonic Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sonic Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia. SONIC HEALTHCARE operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 41000 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Sonic Pink Sheet

Sonic Healthcare financial ratios help investors to determine whether Sonic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sonic with respect to the benefits of owning Sonic Healthcare security.